Kamenecka TM - Search Results

1

Synthesis and SAR of piperazine amides as novel c-jun N-terminal kinase (JNK) inhibitors.

Shin Y, Chen W, Habel J, Duckett D, Ling YY, Koenig M, He Y, Vojkovsky T, LoGrasso P, Kamenecka TM. Shin Y, et al. Among authors: kamenecka tm. Bioorg Med Chem Lett. 2009 Jun 15;19(12):3344-7. doi: 10.1016/j.bmcl.2009.03.086. Epub 2009 Mar 26. Bioorg Med Chem Lett. 2009. PMID: 19433357 Free PMC article.

2

N-(arylacetyl)-biphenylalanines as potent VLA-4 antagonists.

Li B, de Laszlo SE, Kamenecka TM, Kopka IE, Durette PL, Lanza T Jr, MacCoss M, Tong S, Mumford RA, McCauley ED, Van Riper G, Schmidt JA, Hagmann WK. Li B, et al. Among authors: kamenecka tm. Bioorg Med Chem Lett. 2002 Aug 19;12(16):2141-4. doi: 10.1016/s0960-894x(02)00366-9. Bioorg Med Chem Lett. 2002. PMID: 12127523

3

Dipyridyl amines: potent metabotropic glutamate subtype 5 receptor antagonists.

Kamenecka TM, Bonnefous C, Govek S, Vernier JM, Hutchinson J, Chung J, Reyes-Manalo G, Anderson JJ. Kamenecka TM, et al. Bioorg Med Chem Lett. 2005 Oct 1;15(19):4350-3. doi: 10.1016/j.bmcl.2005.06.059. Bioorg Med Chem Lett. 2005. PMID: 16039855

4

3,5-Disubstituted quinolines as novel c-Jun N-terminal kinase inhibitors.

Jiang R, Duckett D, Chen W, Habel J, Ling YY, LoGrasso P, Kamenecka TM. Jiang R, et al. Among authors: kamenecka tm. Bioorg Med Chem Lett. 2007 Nov 15;17(22):6378-82. doi: 10.1016/j.bmcl.2007.08.054. Epub 2007 Aug 26. Bioorg Med Chem Lett. 2007. PMID: 17911023

5

Partial agonists activate PPARgamma using a helix 12 independent mechanism.

Bruning JB, Chalmers MJ, Prasad S, Busby SA, Kamenecka TM, He Y, Nettles KW, Griffin PR. Bruning JB, et al. Among authors: kamenecka tm. Structure. 2007 Oct;15(10):1258-71. doi: 10.1016/j.str.2007.07.014. Structure. 2007. PMID: 17937915 Free article.

6

Kinetic mechanism and inhibitor characterization for c-jun-N-terminal kinase 3alpha1.

Ember B, Kamenecka T, LoGrasso P. Ember B, et al. Biochemistry. 2008 Mar 11;47(10):3076-84. doi: 10.1021/bi701852z. Epub 2008 Feb 13. Biochemistry. 2008. PMID: 18269248

7

Inhibitors of c-jun-N-terminal kinase (JNK).

LoGrasso P, Kamenecka T. LoGrasso P, et al. Mini Rev Med Chem. 2008 Jul;8(8):755-66. doi: 10.2174/138955708784912120. Mini Rev Med Chem. 2008. PMID: 18673131

8

Structure-activity relationships and X-ray structures describing the selectivity of aminopyrazole inhibitors for c-Jun N-terminal kinase 3 (JNK3) over p38.

Kamenecka T, Habel J, Duckett D, Chen W, Ling YY, Frackowiak B, Jiang R, Shin Y, Song X, LoGrasso P. Kamenecka T, et al. J Biol Chem. 2009 May 8;284(19):12853-61. doi: 10.1074/jbc.M809430200. Epub 2009 Mar 4. J Biol Chem. 2009. PMID: 19261605 Free PMC article.

9

Synthesis, biological evaluation, X-ray structure, and pharmacokinetics of aminopyrimidine c-jun-N-terminal kinase (JNK) inhibitors.

Kamenecka T, Jiang R, Song X, Duckett D, Chen W, Ling YY, Habel J, Laughlin JD, Chambers J, Figuera-Losada M, Cameron MD, Lin L, Ruiz CH, LoGrasso PV. Kamenecka T, et al. J Med Chem. 2010 Jan 14;53(1):419-31. doi: 10.1021/jm901351f. J Med Chem. 2010. PMID: 19947601 Free PMC article.

10

Synthesis and SAR of 4-(pyrazol-3-yl)-pyridines as novel c-jun N-terminal kinase inhibitors.

Noël R, Shin Y, Song X, He Y, Koenig M, Chen W, Ling YY, Lin L, Ruiz CH, LoGrasso P, Cameron MD, Duckett DR, Kamenecka TM. Noël R, et al. Among authors: kamenecka tm. Bioorg Med Chem Lett. 2011 May 1;21(9):2732-5. doi: 10.1016/j.bmcl.2010.11.104. Epub 2010 Dec 1. Bioorg Med Chem Lett. 2011. PMID: 21185177 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters